Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × INDUSTRY × Mastocytosis, Systemic × Clear all

Phase

Phase 2 8 Phase 1 5 Phase 3 2 Phase 1/2 2 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 66 Breast Neoplasms 64 Prostatic Neoplasms 45 Carcinoma, Non-Small-Cell Lung 40 Neoplasm Metastasis 23 Colorectal Neoplasms 21 Pain 19 Multiple Myeloma 19 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 16 Anemia 16 Keratosis, Actinic 15 Lung Neoplasms 14 Cancer Pain 14 Lymphoma, Non-Hodgkin 12 Lymphoma, Follicular 11 Leukemia 11 Leukemia, Lymphocytic, Chronic, B-Cell 10 Carcinoma, Renal Cell 10 Carcinoma, Hepatocellular 9 Carcinoma 9 Neuroendocrine Tumors 8 Melanoma 8 Lymphoma 8 Ovarian Neoplasms 7 Leukemia, Myeloid, Acute 7 Uterine Cervical Neoplasms 6 Recurrence 6 Gastrointestinal Stromal Tumors 6 Stomatitis 5 Stomach Neoplasms 5

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06748001 2026-02-09

Avapritinib Rollover Study

Blueprint Medicines Corporation

Phase 4 Recruiting

Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡